Being Born During a Flu Pandemic May Increase Your Risk of Death During Another Flu Pandemic
While past exposure to influenza A viruses often builds immunity to similar, and sometimes different, strains of the virus, Canadian researchers are calling for more attention to exceptions to that rule.
New data analysis suggests that people born at the time of the 1957 H2N2 or Asian Flu pandemic were at a higher risk of dying during the 2009 H1N1 Swine Flu pandemic as well as the resurgent H1N1 outbreak in 2013-2014. And it is not the first time this has happened.
Results of the study by researchers of McMaster University and the Université de Montréal were published today in mBio, published by the American Society for Microbiology.
“Reported situations in which previous influenza virus exposures have enhanced susceptibility are rare and poorly understood,” said Matthew Miller, senior author of the paper, an assistant professor of biochemistry and biomedical sciences at McMaster University, and senior researcher with its Michael G. DeGroote Institute of Infectious Disease Research.
“This study’s results have important implications for pandemic risk assessment and should inform laboratory studies aimed at uncovering what’s responsible for this effect.”
The influenza A virus continues to pose one of the most pressing threats to global public health due to its tendency to cause a pandemic. Over the last 100 years alone, at least five such pandemics have occurred, including the 1918 H1N1 Spanish Flu, the 1957 H2N2 Asian Flu, the 1968 H3N2 “Hong Kong Flu”, the 1977 Russian Flu and the 2009 H1N1 Swine Flu.
Miller and the teams from both universities reviewed monthly mortality and influenza circulation data from October 1997 to July 2014 in the United States and Mexico. They identified peaks in excess mortality during the 2009 H1N1 Swine Flu pandemic and during the resurgent 2013-2014 H1N1 outbreak among people born in 1952.
The results align with at least two previous influenza A virus pandemics, in 1918 and 1968, when there were higher death rates among those born during previous pandemic years in 1890 and 1918, respectively.
“We suggest the phenomenon of 1918 is not unique,” Miller said. “We believe that exposure to pandemic influenza early in life is a risk factor for mortality during subsequent cross-strain pandemics.”
Miller suggested further research is needed so appropriate vaccines may be developed.
“We believe there is an important piece missing in this puzzle that has been overlooked in most investigations on pandemic influenza,” he said.
“Our research highlights the urgent need to develop more broadly-protective ‘universal’ influenza virus vaccines – capable of providing protection against both seasonal and pandemic influenza strains.”
This article has been republished from materials provided by McMaster University. Note: material may have been edited for length and content. For further information, please contact the cited source.
Pandemic Paradox: Early Life H2N2 Pandemic Influenza Infection Enhanced Susceptibility to Death during the 2009 H1N1 Pandemic. Alain Gagnon, Enrique Acosta, Stacey Hallman, Robert Bourbeau, Lisa Y. Dillon, Nadine Ouellette, David J. D. Earn, D. Ann Herring, Kris Inwood, Joaquin Madrenas, Matthew S. Miller. 16 January 2018 mBio vol. 9 no. 1 e02091-17 doi: 10.1128/mBio.02091-17.
Strong Immune Response Linked to Stunted Growth in ChildrenNews
An overactive immune system during childhood among young people in Ecuador’s indigenous Shuar population comes with a cost: stunted growth.READ MORE
Flavins Keep a Handy Helper in Their PocketNews
A team has now shown in detail how oxygen interacts with the flavin in an enzyme - revealing for the first time precisely how it works. Flavins play a key role in metabolic processes, in the immune system and in neural development in humans - and are equally important to bacteria, fungi and plants.READ MORE
Comments | 0 ADD COMMENT
15th Symposium on the Practical Applications of Mass Spectrometry in the Biotechnology Industry
Sep 09 - Sep 12, 2018
CE in the Biotechnology & Pharmaceutical Industries: 20th Symposium on the Practical Applications for the Analysis of Proteins, Nucleotides & Small Molecules
Sep 09 - Sep 12, 2018